MTAP-deleted NSCLC
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| A Phase 2 Study of Anvumetostat in Participants With MTAP-deleted Advanced NSCLC (MTAPESTRY 201) (NCT06593522) | Amgen | 2024-12-26 |
Track MTAP-deleted NSCLC automatically
Every clearance here is in the API, with alerts when new ones post.